E7 TCR T cells

· National Cancer Institute

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for E7 TCR T cells, covering 2026-03-09 to 2026-03-09. Get the full timeline:

Most recent: Clinical Trial Update: E7 TCR T Cells for Human Papillomavirus-Associated Cancers [Phase 1, Phase 2]